Shandong Xinhua Pharmaceutical Co (HKSE:00719) Cyclically Adjusted Book per Share: HK$2.41 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00719 Shandong Xinhua Pharmaceutical Co Ltd HKSE:00719
91 GF Score
Price HK$6.18
GF Value HK$7.64
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shandong Xinhua Pharmaceutical Co Cyclically Adjusted Book per Share?

Shandong Xinhua Pharmaceutical Co HKSE:00719 +0.08% 91 Cyclically Adjusted Book per Share is HK$2.41 as of Mar. 2026. GuruFocus rates HKSE:00719 with a GF Score™ of 91/100 and a GF Value™ of HK$7.64 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Shandong Xinhua Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2026 was HK$8.720. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is HK$2.41 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shandong Xinhua Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 8.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 7.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 7.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 6.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Shandong Xinhua Pharmaceutical Co was 7.60% per year. The lowest was 1.40% per year. And the median was 5.50% per year.

As of today (2026-08-03), Shandong Xinhua Pharmaceutical Co's current stock price is HK$6.175. Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was HK$2.41. Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 2.56.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shandong Xinhua Pharmaceutical Co was 10.55. The lowest was 1.57. And the median was 2.95.


Shandong Xinhua Pharmaceutical Co  (HKSE:00719) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=6.175/2.41
=2.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shandong Xinhua Pharmaceutical Co was 10.55. The lowest was 1.57. And the median was 2.95.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Shandong Xinhua Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Shandong Xinhua Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Xinhua Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Shandong Xinhua Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.71 1.20 1.34 1.89 2.36

Shandong Xinhua Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.99 2.23 2.53 2.36 2.41

HKSE:00719 vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Xinhua Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


HKSE:00719
91GF Score
Shandong Xinhua Pharmaceutical Co Ltd HKSE:00719
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Xinhua Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shandong Xinhua Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=8.72/116.3033*116.3033
=8.720

Current CPI (Mar. 2026) = 116.3033.

Shandong Xinhua Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 3.780 101.400 4.336
201609 3.830 102.400 4.350
201612 3.750 102.600 4.251
201703 3.868 103.200 4.359
201706 4.093 103.100 4.617
201709 4.216 104.100 4.710
201712 4.724 104.500 5.258
201803 5.019 105.300 5.543
201806 4.950 104.900 5.488
201809 4.822 106.600 5.261
201812 4.924 106.500 5.377
201903 5.249 107.700 5.668
201906 5.133 107.700 5.543
201909 5.124 109.800 5.427
201912 5.313 111.200 5.557
202003 5.365 112.300 5.556
202006 5.321 110.400 5.606
202009 5.692 111.700 5.927
202012 6.145 111.500 6.410
202103 6.386 112.662 6.592
202106 6.413 111.769 6.673
202109 6.544 112.215 6.782
202112 6.769 113.108 6.960
202203 7.086 114.335 7.208
202206 6.786 114.558 6.889
202209 6.634 115.339 6.689
202212 6.881 115.116 6.952
202303 7.308 115.116 7.383
202306 7.021 114.558 7.128
202309 7.122 115.339 7.182
202312 7.381 114.781 7.479
202403 7.585 115.227 7.656
202406 7.500 114.781 7.599
202409 7.860 115.785 7.895
202412 7.810 114.893 7.906
202503 8.014 115.116 8.097
202506 8.124 114.907 8.223
202509 8.158 115.471 8.217
202512 8.342 115.832 8.376
202603 8.720 116.303 8.720

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of HK$2.41 mean?
Shandong Xinhua Pharmaceutical Co (HKSE:00719) has a Cyclically Adjusted Book per Share of HK$2.41 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Shandong Xinhua Pharmaceutical Co and its competitors.
Is Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Shandong Xinhua Pharmaceutical Co's current Cyclically Adjusted Book per Share is HK$2.41. Overall, Shandong Xinhua Pharmaceutical Co has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS?
Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Book per Share of HK$2.41 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Shandong Xinhua Pharmaceutical Co and its competitors. Shandong Xinhua Pharmaceutical Co's current Cyclically Adjusted Book per Share is HK$2.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Xinhua Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Xinhua Pharmaceutical Co (HKSE:00719) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$7.64, compared to a current price of HK$6.18 — trading 19.2% below its estimated fair value. The current Cyclically Adjusted Book per Share is HK$2.41. Shandong Xinhua Pharmaceutical Co's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Shandong Xinhua Pharmaceutical Co (HKSE:00719), the current Cyclically Adjusted Book per Share is HK$2.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Xinhua Pharmaceutical Co (HKSE:00719) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Xinhua Pharmaceutical Co stock appears to be undervalued. The current stock price of HK$6.18 is trading 19.2% below its estimated GF Value™ of HK$7.64. GuruFocus considers Shandong Xinhua Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for HKSE:00719:

  • Cyclically Adjusted Book per Share: HK$2.41
  • GF Value™: HK$7.64 vs. price of HK$6.18 (19.2% below fair value)
  • GF Score™: 91/100 with 4 warning signs

No single metric tells the full story. See the HKSE:00719 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Xinhua Pharmaceutical Co Business Description

Other Exchanges XIN:Germany000756:China
Address No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo, Shandong, CHN, 255086
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates various segments namely Chemical raw materials, Preparations, Pharmaceutical intermediates and other products. The company is mainly engaged in the business of development, manufacture and sale of bulk pharmaceuticals, preparations and chemical products.
91GF Score

Get the complete analysis for HKSE:00719

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$6.18
Price
HK$7.64
GF Value